Anzeige
Mehr »
Login
Mittwoch, 13.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
582 Leser
Artikel bewerten:
(2)

Tectonic Gold Plc - Specimen Hill and Joint Venture Update

Finanznachrichten News

Tectonic Gold Plc - Specimen Hill and Joint Venture Update

PR Newswire

25 February 2021

TECTONIC GOLD PLC

("Tectonic Gold" or the "Company")

SPECIMEN HILL TECHNICAL PROGRESS AND DIAMOND JOINT VENTURE UPDATE

Tectonic Gold plc (TDIM: TTAU), the Intrusive Related Gold System ("IRGS") explorer, is pleased to share technical findings from our collaborative research program with CODES and diamond production results from our Deep Blue Minerals joint venture in South Africa.

Specimen Hill CODES Research Highlights:

  • Collaborative programme with world leading ore deposit research centre
  • Genetic confirmation that copper and gold samples are close to the intrusive source
  • Reaffirms drill targeting and informs plan for higher density drilling campaign

Deep Blue Production Highlights:

  • January production over 220cts
  • Ramp up program going well
  • Moving into deeper and higher grade ore so expect continued production increases

Mr. Brett Boynton, Managing Director - Tectonic Gold Plc

" Tectonic has an ongoing research collaboration with "CODES" (The Centre for Ore Deposit and Earth Sciences) at the University of Tasmania. Major gold companies such as Newcrest also work with CODES, so this collaboration gives Tectonic an open technical forum across industry and academia.

Using advanced analytics we looked at chemical associations from the rocks at various depths to build a picture of the temperature and pressure of the gold and copper bearing fluids that came up with the intrusive to form the deposit at Specimen Hill. From this we have confirmed, amongst other things, that our methodical drilling program is moving through the deposit towards the intrusive source. We will take this information back into the model to further refine our follow up campaign with higher density drilling for resource definition.

It is important to get the same positive response from a range of tests to confirm our thinking. Often explorers hit an intersection of gold and are encouraged to drill without a clear roadmap and they end up putting in a lot of unsuccessful holes and running out of money. Working with CODES keeps us disciplined and on track.

Deep Blue Minerals JV Highlights:

Our joint venture with AIM listed Kazera Global Investments is really coming into its own now with the production ramp up program progressing well. Initial production in December was around 50 carats, so delivering this significant increase in output as we move into the higher-grade zone is an excellent result. Tectonic has a non-diluting 10% interest in Deep Blue and holds 20 million shares in Kazera, with options for another 20 million shares at 0.5p."

About Tectonic Gold:

Tectonic Gold is a specialist gold exploration company, focused on the identification and delineation of large-scale, multimillion-ounce Intrusion Related Gold Systems ("IRGS"). Tectonic Gold holds a number of gold discoveries in the New England Orogen in Eastern Australia, a prolific gold region that is home to Australia's two largest gold production companies, Newcrest Mining and Evolution Mining. Rio Tinto, one of the largest copper companies in the world has recently taken a large tenement alongside Tectonic's Specimen Hill project

Qualified Persons:

Mr Jonathan Robbeson - BSc (Hons1), MEconGeol, MMinEng, (CP Geo) is a full-time employee Signature Gold Limited and is a registered Chartered Professional (Geology) with the Australian Institute of Mining and Metallurgy (AusIMM - 304542). Mr Robbeson has sufficient experience that is relevant to the style of mineralisation and type of deposit under consideration and the activity being undertaken to qualify as a Competent Person as defined in the Note for Mining Oil & Gas Companies, June 2009, of the London Stock Exchange and the 2012 Edition of the 'Australian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves' (JORC Code). Mr Robbeson consents to the inclusion in the release of the matters based on his information in the form and context in which it appears.

JORC Table 1 information for this release on Specimen Hill can be found on the Company website.

The Directors of the Company accept responsibility for the contents of this announcement.


For further information, please contact:

Tectonic Gold plc
Brett Boynton
Sam Quinn
www.tectonicgold.com.
@tectonic_gold
+61 2 9241 7665
Financial Adviser, Corporate Adviser and Broker
VSA Capital Limited
Andrew Raca - Corporate Finance
Andrew Monk - Corporate Broking
+44 20 3005 5000

Ends

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

© 2021 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.